Amylyx Pharmaceuticals said in a press release Monday that Canada is the first country in the world to give the regulatory greenlight for Albrioza as a treatment for the devastating neurodegenerative disease.
Christian Dube says the members of the committee studying the bill have agreed that the subject is too complex to be pushed through without all the necessary time needed to study it.
